MCOLN1 and pancreatic ductal adenocarcinoma: Similarly, by evaluating the expression levels of TRPML1 in tumor tissues from 82 pancreatic ductal adenocarcinoma (PDAC) patients, Hu et al. found that a higher TRPML1 expression level is associated with the poor clinical characteristics of these PDAC patients [123].